Revenue | ₹1,891.81Cr |
Net Profits | ₹132.97Cr |
Net Profit Margins | 7.03% |
Alembic Pharmaceuticals Ltd’s revenue jumped 11.11% since last year same period to ₹1,891.81Cr in the Q3 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -1.39% fall in its revenue since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit fell -3.94% since last year same period to ₹132.97Cr in the Q3 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -28.01% fall in its net profits since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit margin fell -13.55% since last year same period to 7.03% in the Q3 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated -27% fall in its net profit margins since last 3-months.
The revenue for Alembic Pharmaceuticals Ltd in the Q3 results 2025 was ₹1,891.81Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q3 results 2025 was ₹132.97Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q3 results 2025 was 7.03%.
The revenue for Alembic Pharmaceuticals Ltd in the Q3 results 2024 was ₹1,702.60Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q3 results 2024 was ₹138.42Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q3 results 2024 was 8.13%.